Pharma Journalist -

SMi Reports: Lynne Ensor, Vice President, Technical, Parexel International discussed the latest development in the field, her thoughts on the developing regulatory environment and more.…
Read More...

SMi Reports: Martin Everett, Chief Scientific Officer, Antabio, who will be speaking at Superbugs & Superdrugs, discussed how the AMR market has matured over the last year, what…
Read More...

Harbour BioMed (HBM) announced completion of a Phase 1 study of HBM9161, a fully human anti-FcRn monoclonal antibody, to evaluate its safety, tolerability, pharmacokinetics and…
Read More...

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced it has entered…
Read More...

This March, Oxford Global is hosting the Formulation & Delivery Series US in San Diego, CA. The Pre-Event Newsletter gives an insight into who is attending the event. Take 5 minutes…
Read More...

Vifor Pharma announced a strategic partnership with Fresenius Kabi to create a new joint company based in the People’s Republic of China expanding its access to the second largest…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq…
Read More...

LumaCyte, an advanced bioanalytical instrumentation company specializing in vaccine and cell and gene therapy bioprocess, production, and R&D analytical capabilities, announces its…
Read More...

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, announced it has…
Read More...

FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced the U.S. Food and Drug Administration (FDA) has granted…
Read More...